FDA clears GE's cardiac US system
Article Thumbnail ImageApril 25, 2012 -- The U.S. Food and Drug Administration (FDA) has cleared GE Healthcare's latest version of its Vivid E9 cardiovascular ultrasound system.
Member Sign In:
  MemberID or E-mail Address:

New AuntMinnie.com Members

Becoming a Member is FREE!

  • Real-time radiology-specific news
  • Case of the Day and Teaching Files
  • Focused topics digital communities
  • Lively, discussion groups
  • Medical imaging bookstore
  • SalaryScan
  • Job Boards
  • Online CME
  • Bookstore, market reports, more …
  • Conference Calendar
  • User-controlled eNewsletters
  • … registration is FREE and easy!
  • Vivid E9 Breakthrough 2012 (BT12) includes a 4D transducer for transesophageal echocardiography (TEE). This transducer allows clinicians to view images of the heart during assessment and diagnosis performed in the echo lab, and it supports invasive surgical procedures in the operating room, according to GE.

    With the TEE transducer, Vivid E9 can also be used for procedures such as mitral valve repair, transcatheter aortic valve repair, atrial septal defect closures, and patent foramen ovale closures, the company said.

    Vivid E9 BT12 has the CE Mark and has been available for sale in Europe and other countries around the world.

    || About || Advertising || AuntMinnieCME.com || Bookstore || Breast MRI || Career Center || Case of the Day || Communities || Conferences || Contact Us || ECR News 2014 || Education || Equipment Classifieds || Europe || Facebook || Forums || Home || Links || Marketplace || Middle East || Mobile || Molecular Breast Imaging || New Installations || News in Brief || People in the News || Privacy Policy || RSNA News 2013 || Reference || Salary Survey Results || Trends in Radiology || Twitter || Vendor Connect || Webinars || XML/RSS ||

    Copyright © 2014 AuntMinnie.com. All Rights Reserved.